Laboratory freeze dryer Lyomega series

The main challenges in today's generic and specialty drug and biotech markets are shortening time to market and increasing productivity while assuring quality and reducing costs. Freeze-drying is not a novel technology by any means and the pharmaceutical industry, influenced by safety and validation requirements has introduced policies that tend to restrict process improvements. The focus of the industry has been focused on repeatability of the same process, and knowledge on how the process affects the product has had lesser importance providing the quality is assured. Under these circumstances, the most appropriate approach to reduce cost is through reduction in cycle times. Telstar works in partnership with clients to develop the most appropriate solution, offering reliable and trouble-free process technology based on many years of experience working with the pharmaceutical and biotech industries across a variety of pharmaceutical applications.